June PBS listings ready to roll

Posted 14 May 2025 AM

Despite a pre-election reimbursement frenzy in May, there are still more than 10 potential June PBS listings jostling to become the first to be subsidised under the Albanese Government's second term.

At the front of the queue is Servier Laboratories' first-in-class IDH1 inhibitor Tibsovo for the treatment of locally advanced or metastatic cholangiocarcinoma with an IDH1 mutation, in patients who have previously progressed on chemotherapy.

To see the whole article, please login